1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Freedonia Focus on Excipients: United States

Freedonia Focus on Excipients: United States

  • March 2014
  • -
  • Freedonia Focus
  • -
  • 28 pages

This report forecasts US excipient demand in pounds and US dollars at the manufacturers' level to 2018. Total demand in dollars is segmented by product in terms of polymers, alcohols, minerals, gelatin, and other products. Total demand in dollars is also segmented by application as follows: fillers and diluents, binders, suspension and viscosity agents, coatings, solvents, and other applications.

To illustrate historical trends, total demand in dollars is provided in an annual series from 2003 to 2013; the various segments are reported at five-year intervals for 2008 and 2013. An Industry Overview section defines products and applications, discusses market drivers and constraints, identifies substitute products when applicable, and provides pertinent background on pharmaceutical dosage formulations and the regulatory environment.

A Demand Forecasts section assesses the impact of key drivers and constraints on each product and application segment over the forecast period.

Further analysis includes an Industry Structure section, which surveys the supply base and profiles the leading suppliers competing to serve US demand. A one-page, introductory Highlights section summarizes key findings from this 28-page report, and a Resources section lists contributing sources as well as resources available for further research.

Table Of Contents

Freedonia Focus on Excipients: United States
HIGHLIGHTS

INDUSTRY OVERVIEW
Market Size and Trends
Product Segmentation
Application Segmentation
Pharmaceutical Dosage Formulations
Regulatory Overview

DEMAND FORECASTS
Market Environment
Product Forecasts
Application Forecasts

INDUSTRY STRUCTURE
Industry Composition and Characteristics
Additional Companies Cited

RESOURCES

LIST OF TABLES AND CHARTS

Chart 1 | United States: Excipient Demand Trends, 2003-2013
Chart 2 | United States: Excipient Demand by Product, 2013
Chart 3 | United States: Excipient Demand by Application, 2013
Chart 4 | United States: Pharmaceutical Shipments by Dosage Formulation, 2013
Table 1 | United States: Key Indicators for Excipient Demand; 2008, 2013, 2018 (US$ bil)
Table 2 | United States: Excipient Demand by Product; 2008, 2013, 2018 (US$ mil)
Table 3 | United States: Excipient Demand by Application; 2008, 2013, 2018 (US$ mil)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.